suppresses TGF--driven fibrosis and cardiac/renal remodeling: PMC4889319
Mosenzon O, Blicher TM, Rosenlund S, Eriksson JW, Heller S, Hels OH, et al Efficacy and safety of oral semaglutide in patients with type 2 diabetes and moderate renal impairment (PIONEER 5): A placebo-controlled, randomised, phase 3a trial Lancet Diabetes Endocrinol
Bizzarri, M., Fuso, A., Dinicola, S., Cucina, A
The key finding for bodybuilders: despite dramatically greater total weight loss, retatrutide did not cause disproportionately greater lean mass loss
Finding the right balance of fiber, hydration, physical activity, and possibly supplements can help manage GLP-1 side effects while you continue to receive the therapeutic benefits of your medication